drugset / Trial / NCT00882466
The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the effect of intravenous human recombinant erythropoietin on the reperfusion injury at primary percutaneous coronary intervention in patients with acute myocardial infarction.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 50 iu/kg | Intravenous |